Loading…
MicroPort Scientific Corporation, through its subsidiary Endovascular Technology Corporation, acquired the shares of Lombard Medical Limited and Lombard Medical Technologies GmbH in a restructuring under UK bankruptcy law. Lombard Medical, Inc. will be liquidated.
MicroPort Scientific Corporation and Chinese PE firm Yunfeng Capital will acquire the cardiac rhythm management (CRM) business of LivaNova for $190 million in cash.
Lombard Medical and MicroPort Scientific Corporation announced a strategic partnership and $15 million investment by MicroPort, including exclusive marketing rights for Aorfix and Altura stent grafts in China and Brazil, and a component supply agreement.